| Title | CNS Neuroscience and Therapeutics |
| Abbreviation | CNS Neurosci. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (Q1); Pharmacology (medical) (Q1); Physiology (medical) (Q1); Psychiatry and Mental Health (Q1) |
| h-index | 99 |
| Overall Rank/Ranking | 1970 |
| SCImago Journal Rank (SJR) | 1.676 |
| Impact Score | 5.66 |
| Publisher | John Wiley and Sons Inc |
| Country | United Kingdom |
| ISSN | 17555949, 17555930 |
| Best Quartile | Q1 |
| Coverage History | 2008-2025 |
CNS Neuroscience & Therapeutics (formerly CNS Drug Reviews) publishes original research papers, timely reviews and reports of novel findings of therapeutic relevance. The journal focuses on the neuroscience, phenomenology and pathophysiology, as well as pharmacologic and psychosocial therapeutics, of psychiatric and related disorders.
CNS Neuroscience and Therapeutics is a journal covering the technologies/fields/categories related to Pharmacology (Q1); Pharmacology (medical) (Q1); Physiology (medical) (Q1); Psychiatry and Mental Health (Q1). It is published by John Wiley and Sons Inc. The overall rank of CNS Neuroscience and Therapeutics is 1970. According to SCImago Journal Rank (SJR), this journal is ranked 1.676. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 99. The best quartile for this journal is Q1.
The ISSN of CNS Neuroscience and Therapeutics journal is 17555949, 17555930. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. CNS Neuroscience and Therapeutics is cited by a total of 4212 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of CNS Neuroscience and Therapeutics is 5.66, which is computed in 2025 as per its definition. CNS Neuroscience and Therapeutics IF is increased by a factor of 0.71 and approximate percentage change is 14.34% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of CNS Neuroscience and Therapeutics is 5.66. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 5.66 |
| 2023 | 4.95 |
| 2022 | 5.29 |
| 2021 | 6.22 |
| 2020 | 4.03 |
| 2019 | 3.57 |
| 2018 | 3.00 |
| 2017 | 3.05 |
| 2016 | 3.34 |
| 2015 | 3.26 |
| 2014 | 3.37 |
CNS Neuroscience and Therapeutics has an h-index of 99. It means 99 articles of this journal have more than 99 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of CNS Neuroscience and Therapeutics is 17555949, 17555930. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of CNS Neuroscience and Therapeutics is 1970. According to SCImago Journal Rank (SJR), this journal is ranked 1.676. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.676 |
| 2023 | 1.473 |
| 2022 | 1.381 |
| 2021 | 1.364 |
| 2020 | 1.403 |
| 2019 | 1.241 |
| 2018 | 1.122 |
| 2017 | 1.380 |
| 2016 | 1.567 |
| 2015 | 1.553 |
| 2014 | 1.619 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1970 |
| 2023 | 2327 |
| 2022 | 2452 |
| 2021 | 2478 |
| 2020 | 2540 |
| 2019 | 3074 |
| 2018 | 3675 |
| 2017 | 2651 |
| 2016 | 2197 |
| 2015 | 2243 |
| 2014 | 2023 |
CNS Neuroscience and Therapeutics is published by John Wiley and Sons Inc. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2008-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of CNS Neuroscience and Therapeutics is CNS Neurosci. Ther.. This abbreviation ('CNS Neurosci. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (Q1); Pharmacology (medical) (Q1); Physiology (medical) (Q1); Psychiatry and Mental Health (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
CNS Neuroscience and Therapeutics latest impact IF is 5.66. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 6.22 (2021) and 3.00 (2018), respectively, in the last 11 years. Moreover, its average IS is 4.16 in the previous 11 years.
The CNS Neuroscience and Therapeutics has an SJR (SCImago Journal Rank) of 1.676, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.676 in 2024 and the lowest being 1.122 in 2018. Furthermore, the average SJR of the CNS Neuroscience and Therapeutics over the previous 11-year period stands at 4.16.
The latest h-index of the CNS Neuroscience and Therapeutics is 99.
The CNS Neuroscience and Therapeutics is published by the John Wiley and Sons Inc, with its country of publication being the United Kingdom.
The CNS Neuroscience and Therapeutics is currently ranked 1970 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1970 in 2024 and its lowest position of 3675 in 2018.
The standard ISO4 abbreviation for the CNS Neuroscience and Therapeutics is CNS Neurosci. Ther..
CNS Neuroscience and Therapeutics is classified as a journal that the John Wiley and Sons Inc publishes.
The CNS Neuroscience and Therapeutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The CNS Neuroscience and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 17555949, 17555930.
The best quartile for the CNS Neuroscience and Therapeutics is Q1 (2024).
The CNS Neuroscience and Therapeutics coverage history can be summarized as follows: 2008-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| Entrepreneurship Theory and Practice | journal | 168 | SAGE Publications Ltd | 212 | 13.35 |
| Archives of Phytopathology and Plant Protection | journal | 16692 | Taylor and Francis Ltd. | 35 | 1.42 |
| Mathematical Modelling and Analysis | journal | 9616 | Vilnius Gediminas Technical University | 31 | 1.49 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 17452 | Taylor and Francis Ltd. | 27 | 1.17 |
| Socialism and Democracy | journal | 27160 | Taylor and Francis Ltd. | 19 | 0.20 |
| Transnational Corporations | journal | 13970 | UNCTAD United Nations Conference on Trade and Development | 30 | 1.63 |
| Howard Journal of Communications | journal | 14582 | Taylor and Francis Ltd. | 42 | 1.27 |
| Studies in Continuing Education | journal | 4850 | Routledge | 44 | 3.35 |
| Palaeontographica Abteilung B: Palaeophytologie | book series | 10600 | Schweizerbart Science Publishers | 18 | 4.25 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 5.66 |
| 2023 | 4.95 |
| 2022 | 5.29 |
| 2021 | 6.22 |
| 2020 | 4.03 |
| 2019 | 3.57 |
| 2018 | 3.00 |
| 2017 | 3.05 |
| 2016 | 3.34 |
| 2015 | 3.26 |
| 2014 | 3.37 |
